Pediatric Ethics in the Age of Molecular Medicine

Pediatric Clinics of North America

Volumn 53, Issue 4, 2006, Pages 639-648

  Barfield, Raymond C ^a   Kodish, Eric ^b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPHENIDATE; ORPHAN DRUG; PSYCHOTROPIC AGENT;

BIOETHICS; BIOINFORMATICS; BRAIN FUNCTION; CANCER SUSCEPTIBILITY; CAREGIVER; CHILDHOOD DISEASE; DECISION MAKING; DNA SEQUENCE; DRUG COST; DRUG INDUSTRY; ECONOMIC ASPECT; EMBRYONIC STEM CELL; ENVIRONMENTAL FACTOR; FAMILY HISTORY; FERTILIZATION IN VITRO; FINANCIAL MANAGEMENT; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC SUSCEPTIBILITY; GENOMICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEREDITY; HLA SYSTEM; HUMAN; MEDICAL ETHICS; MEMORY DISORDER; NANOTECHNOLOGY; NERVE CELL PLASTICITY; NEUROSCIENCE; PEDIATRICS; PHARMACOGENOMICS; PROTEOMICS; REVIEW; SEIZURE; SINGLE NUCLEOTIDE POLYMORPHISM; SOCIAL DISCRIMINATION; SOCIOECONOMICS;

EMBRYO RESEARCH; GENOMICS; HUMANS; MOLECULAR BIOLOGY; PEDIATRICS; PHARMACOGENETICS; STEM CELL TRANSPLANTATION;

EID: 33746228281     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcl.2006.05.001     Document Type: Review

References (38)

1. Feigin R.D. Prospects for the future of child health through research. JAMA 294 (2005) 1373-1379
2. Smith B. Analogy in moral deliberation: the role of imagination and theory in ethics. J Med Ethics 28 (2002) 244-248
3. World Health Organization. Genetic databases: assessing the benefits and the impact on human and patient rights (2003), World Health Organization, Geneva
4. Farah M.J. Neuroethics: the practical and the philosophical. Trends Cogn Sci 9 (2005) 34-40
5. Kodish E. Informed consent for pediatric research: is it really possible?. J Pediatr 142 (2003) 89-90
6. Global Forum for Health Research. The 10/90 report on health research 2000 (2000), Global Forum for Health Research, Geneva
7. Hocquette J.F. Where are we in genomics?. J Physiol Pharmacol 56 Suppl 3 (2005) 37-70
8. Segal E., Friedman N., Kaminski N., et al. From signatures to models: understanding cancer using microarrays. Nat Genet 37 Suppl (2005) S38-S45
9. Joos L., Eryuksel E., and Brutsche M.H. Functional genomics and gene microarrays: the use in research and clinical medicine. Swiss Med Wkly 133 (2003) 31-38
10. D'Ambrosio C., Gatta L., and Bonini S. The future of microarray technology: networking the genome search. Allergy 60 (2005) 1219-1226
11. Kuehn B.M. Genetic information: how much can patients handle?. JAMA 294 (2005) 295-296
12. American Society of Clinical Oncology. Policy statement update: genetic testing for cancer susceptibility. J Clin Oncol 21 (2003) 2397-2406
13. Thomas S.M. Society and ethics: the genetics of disease. Curr Opin Genet Dev 14 (2004) 287-291
14. Nowlan W. Human genetics. A rational view of insurance and genetic discrimination. Science 297 (2002) 195-196
15. Rothenberg K.H., and Terry S.F. Human genetics. Before it's too late: addressing fear of genetic information. Science 297 (2002) 196-197
16. Li W.H., and Sadler L.A. Low nucleotide diversity in man. Genetics 129 (1991) 513-523
17. Lin Z., Owen A.B., and Altman R.B. Genetics. Genomic research and human subject privacy. Science 305 (2004) 183
18. Claerhout B., and DeMoor G.J. Privacy protection for clinical and genomic data. The use of privacy-enhancing techniques in medicine. Int J Med Inform 74 (2005) 257-265
19. Knoppers B.M., and Chadwick R. Human genetic research: emerging trends in ethics. Nat Rev Genet 6 (2005) 75-79
20. UNESCO. Universal declaration on the human genome and human rights. J Med Philos 23 (1998) 334-341
21. Knoppers B.M., Hirtle M., and Glass K.C. Policy forum: genetic technologies. Commercialization of genetic research and public policy. Science 286 (1999) 2277-2278
22. Jacoby L.H., Maloy B., Cirenza E., et al. The basis of informed consent for BMT patients. Bone Marrow Transplant 23 (1999) 711-717
23. Weinshilboum R., and Wang L. Pharmacogenomics: bench to bedside. Nat Rev Drug Discov 3 (2004) 739-748
24. Lipton P. Pharmacogenetics: the ethical issues. Pharmacogenomics J 3 (2003) 14-16
25. Breckenridge A., Lindpaintner K., Lipton P., et al. Pharmacogenetics: ethical problems and solutions. Nat Rev Genet 5 (2004) 676-680
26. Service R.F. Genetics and medicine. Recruiting genes, proteins for a revolution in diagnostics. Science 300 (2003) 236-239
27. Nelson A. Unequal treatment: confronting racial and ethnic disparities in health care. J Natl Med Assoc 94 (2002) 666-668
28. Wilson J.F., Weale M.E., Smith A.C., et al. Population genetic structure of variable drug response. Nat Genet 29 (2001) 265-269
29. Pitman R.K., Sanders K.M., Zusman R.M., et al. Pilot study of secondary prevention of posttraumatic stress disorder with propranolol. Biol Psychiatry 51 (2002) 189-192
30. Diller L.H. The run on Ritalin. Attention deficit disorder and stimulant treatment in the 1990s. Hastings Cent Rep 26 (1996) 12-18
31. Illes J., Blakemore C., Hansson M.G., et al. Science and society: international perspectives on engaging the public in neuroethics. Nat Rev Neurosci 6 (2005) 977-982
32. Tatsuno Y., and Sakai K.L. Language-related activations in the left prefrontal regions are differentially modulated by age, proficiency, and task demands. J Neurosci 25 (2005) 1637-1644
33. Takahashi T., and Tsukahara Y. Pocket Monster incident and low luminance visual stimuli: special reference to deep red flicker stimulation. Acta Paediatr Jpn 40 (1998) 631-637
34. Weissman I. Stem cell research: paths to cancer therapies and regenerative medicine. JAMA 294 (2005) 1359-1366
35. Grewal S.S., Kahn J.P., MacMillan M.L., et al. Successful hematopoietic stem cell transplantation for Fanconi anemia from an unaffected HLA-genotype-identical sibling selected using preimplantation genetic diagnosis. Blood 103 (2004) 1147-1151
36. Verlinsky Y. Designing babies: what the future holds. Reprod Biomed Online 10 Suppl 1 (2005) 24-26
37. Verlinsky Y., Rechitsky S., Sharapova T., et al. Preimplantation HLA testing. JAMA 291 (2004) 2079-2085
38. Burgio G.R., and Locatelli F. Ethics of creating programmed stem-cell donors. Lancet 356 (2000) 1868-1869